Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Identifying early stage colorectal cancer patients in Nigeria

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.02.20
Views: 119

Dr Peter Kingham - Memorial Sloan Kettering Cancer Center, New York, USA

Dr Peter Kingham speaks to ecancer at the 2019 AORTIC conference in Maputo about work looking at identifying early stage colorectal cancer patients in Nigeria, specifically using biomarkers and genetics.

He explains that there are some striking differences between the biology of colorectal cancer in Nigeria and the US, particularly in the microsatellite instability rates.

Dr Kingham states identifying clinical symptoms as key to identifying the disease earlier and highlights a risk score study that helped change the presentation in stage 4 from 65% to 25%.

Related videos

follow us

Donate to ecancer

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation